| Original language | English |
|---|---|
| Pages (from-to) | 424-426 |
| Number of pages | 3 |
| Journal | Coronary Artery Disease |
| Volume | 33 |
| Issue number | 5 |
| DOIs | |
| State | Published - 1 Aug 2022 |
| Externally published | Yes |
Access to Document
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Coronary Artery Disease, Vol. 33, No. 5, 01.08.2022, p. 424-426.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Temporal trends of invasive physiologic assessment of coronary artery stenosis severity
T2 - insights from a quaternary care center in the United States
AU - Gogia, Shawnbir
AU - Edens, Madison
AU - Fall, Khady N.
AU - Petrossian, Gregory
AU - Horst, Jennifer
AU - Jas Garcia, Javier
AU - Ozdemir, Denizhan
AU - Karimi Galougahi, Keyvan
AU - Karmpaliotis, Dimitri
AU - Kirtane, Ajay J.
AU - Ben-Yehuda, Ori
AU - Maehara, Akiko
AU - Mintz, Gary S.
AU - Ali, Ziad A.
N1 - Funding Information: D.K.: Honoraria - Abiomed, Abbott Vascular, Boston Scientific; equity: Saranas, Soundbite, Traverse Vascular. A.J.K.: Institutional funding to Columbia University or Cardiovascular Research Foundation from Medtronic, Boston Scientific, Abbott Vascular, Abiomed, CSI, CathWorks, Siemens, Philips, ReCor Medical. In addition to research grants, institutional funding includes fees paid to Columbia University or Cardiovascular Research Foundation for speaking engagements or consulting; no speaking/consulting fees were personally received. Personal: travel expenses/meals from Medtronic, Boston Scientific, Abbott Vascular, Abiomed, CSI, CathWorks, Siemens, Philips, ReCor Medical, Chiesi, OpSens, Zoll, and Regeneron. A.M.: grant support and consultant - Abbott Vascular and Boston Scientific. G.S.M.: Honoraria - Boston Scientific, Philips, Terumo, and Medtronic. Z.A.A.: institutional research grants to Columbia University – Abbott, Cardiovascular Systems Inc.; consultant – Amgen, AstraZeneca, Boston Scientific.; equity – Shockwave. For the remaining authors, there are no conflicts of interest.
PY - 2022/8/1
Y1 - 2022/8/1
UR - https://www.scopus.com/pages/publications/85135281930
U2 - 10.1097/MCA.0000000000001137
DO - 10.1097/MCA.0000000000001137
M3 - Letter
C2 - 35383598
AN - SCOPUS:85135281930
SN - 0954-6928
VL - 33
SP - 424
EP - 426
JO - Coronary Artery Disease
JF - Coronary Artery Disease
IS - 5
ER -